Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present BioSig Technologies, Inc. (OTC: BSGM).

Full DD Report for BSGM

You must become a subscriber to view this report.


Recent News from (OTC: BSGM)

BioSig Technologies to Present at the MicroCap Leadership Summit
Santa Monica, CA, Aug. 22, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace...
Source: GlobeNewswire
Date: August, 22 2018 08:00
Electrophysiology Devices Market Growth Intensifies on Heels of Latest Technological Advancements
Palm Beach, FL – (August 20, 2018) — The development of the worldwide Electrophysiology market is being driven by a few elements, the most essential of which is the technological advancements. Technological developments and progressions of innovation have prompted the introduction ...
Source: MarketNewsUpdates.com
Date: August, 20 2018 08:33
BioSig Appoints Johnson & Johnson Veteran Amy Scott
Santa Monica, CA, Aug. 20, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace...
Source: GlobeNewswire
Date: August, 20 2018 08:00
Your Daily Pharma Scoop: Catalyst Positive, JNJ Succeeds, Blue Chips Support Tilray
Stocks in News: CBIO, JNJ Catalyst Bio's MarzAA continues to shows positive action in hemophilia study; shares up 4% premarket Discussion: Catalyst Biosciences ( CBIO ) presented updated preliminary at the Hemophilia Drug Development Summit in Boston from Phase 2/3 clinical trial asses...
Source: SeekingAlpha
Date: August, 18 2018 20:56
BioSig Tech closes $6M equity offering
BioSig Technologies ( OTCQB:BSGM -3.9% ) closes its private capital raise yielding ~$6M in proceeds. The company says it has raised ~$12.5M this year. More news on: BioSig Technologies, Inc., Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: August, 17 2018 15:10
BioSig Technologies Closes Private Placement
Santa Monica, CA, Aug. 17, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today an...
Source: GlobeNewswire
Date: August, 17 2018 14:30
BioSig Tech up 5% on FDA approval for ECG data management system
Thinly traded micro cap BioSig Technologies ( OTCQB:BSGM +5.3% ) is up on average volume in response to its announcement that the FDA has granted 510(k) clearance for its PURE EP, a system for acquiring and managing electrocardiographic and intracardiac signals in patients undergoing ele...
Source: SeekingAlpha
Date: August, 15 2018 13:20
FDA Approvals for Cardiac Electrophysiology Products Bright Spot in Healthcare Industry
Palm Beach, FL – (August 14, 2018) — The rising prevalence of cardiac conditions such as flutter, atrial fibrillation and arrhythmia has driven the adoption of medical procedures such as ablation and electrophysiology (EP) study.  Electrophysiology is one of the most rapidly-g...
Source: MarketNewsUpdates.com
Date: August, 14 2018 08:14
BioSig Technologies Announces FDA 510(k) Clearance for PURE EP System
Santa Monica, CA, Aug. 14, 2018 (GLOBE NEWSWIRE) --  BioSig Technologies, Inc. (OTCQB: BSGM), announced that the Company has received 510(k) clearance for its first product, PURE EP System, from the U.S. Food and Drug Administration (FDA).  The non-invasi...
Source: GlobeNewswire
Date: August, 14 2018 08:06
BioSig Technologies Added to LD Micro Index
Santa Monica, CA, Aug. 06, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ( BSGM ), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, announced tha...
Source: GlobeNewswire
Date: August, 06 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-194.444.604.824.4011,866
2018-12-184.164.434.734.16125,782
2018-12-173.904.164.203.9066,891
2018-12-143.983.904.103.8629,329
2018-12-133.994.054.103.9114,001

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-09-1047,17697,29848.4861Short
2018-09-07160,662515,22531.1829Cover
2018-09-0661,578191,72132.1185Cover
2018-09-0552,108191,91027.1523Cover
2018-09-045,93654,72410.8472Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BSGM.


About BioSig Technologies, Inc. (OTC: BSGM)

Logo for BioSig Technologies, Inc. (OTC: BSGM)

BioSig Technologies is a medical device company developing a proprietary technology platform designed to improve the . billion electrophysiology EP marketplace www.biosigtech.com . Led by a proven management team and a veteran, independent Board of Directors, Minneapolis based BioSig Technologies is preparing to commercialize its PURE EP TM System. The technology has been developed to address an unmet need in a large and growing market. The PURE EP System is a novel cardiac signal acquisition and display system which is engineered to assist electrophysiologists in clinical decision making during procedures to diagnose and treat patients with abnormal heart rates and rhythms. BioSig s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. BioSig has partnered with Minnetronix on technology development and is working toward FDA k clearance for the PURE EP System.

 

Contact Information

 

 

Current Management

  • Kenneth L Londoner / CEO
  • Steve Chaussy / CFO
  • Kenneth L Londoner / Chairman
  • Andrew Filler /
  • Seth H. Z. Fischer / Independent Director, Compensation Committee Member
  • Donald E. Foley / Independent Director, Nominating Committee Member
  • Patrick J. Gallagher / Independent Director, Audit Committee Member
  • David Weild IV / Independent Director, Audit Committee Member
  • Jeffrey F. O Donnell, Sr. / Independent Director, Audit Committee Member, Compensation Committee Member
  • Roy T Tanaka / Independent Director, Compensation Committee Member, Nominating Committee Member

Current Share Structure

  • Market Cap: $42,294,837 - 03/15/2018
  • Authorized: 200,000,000 - 10/11/2017
  • Issue and Outstanding: 29,998,466 - 02/27/2018
  • Float: 17,790,755 - 10/11/2017

 


Recent Filings from (OTC: BSGM)

General form for registration of securities under the Securities Act of 1933
Filing Type: S-1Filing Source: edgar
Filing Date: May, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 01 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 04 2018
Amendment to a previously filed 10-K
Filing Type: 10-K/AFiling Source: edgar
Filing Date: March, 26 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: March, 26 2018
Amendment to general form for registration of securities under the Securities Act of 1933
Filing Type: S-1/AFiling Source: edgar
Filing Date: March, 22 2018
General form for registration of securities under the Securities Act of 1933
Filing Type: S-1Filing Source: edgar
Filing Date: February, 28 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 27 2018

 

 


Daily Technical Chart for (OTC: BSGM)

Daily Technical Chart for (OTC: BSGM)


Stay tuned for daily updates and more on (OTC: BSGM)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BSGM)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BSGM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BSGM and does not buy, sell, or trade any shares of BSGM. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/